Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
J&J to Buy Aragon Pharmaceuticals for Cancer Candidate
Bloomberg
Mon, 06/17/13 - 09:15 am
Aragon
JNJ
M&A
ARN-509
prostate cancer
Is Johnson & Johnson A Buy At These Prices?
Wall Street Cheat Street
Sat, 06/15/13 - 01:16 pm
JNJ
Johnson & Johnson's Gut Feeling About the Future of Medicine
Motley Fool
Sat, 06/15/13 - 01:14 pm
JNJ
microbiome
Second Genome
FDA approves new silicone breast implant from J&J
Yahoo/AP
Sat, 06/15/13 - 01:12 pm
breast implants
JNJ
J&J Says It Sells Final Stake in Elan for $332 Million
Bloomberg
Sat, 06/15/13 - 01:09 pm
JNJ
Elan
J&J Says It Sells Final Stake in Elan for $332 Million
Bloomberg
Fri, 06/14/13 - 08:08 am
bapineuzumab
Elan
JNJ
Inside HCV: An Interview with Janssen
Motley Fool
Thu, 06/13/13 - 10:54 am
hepatitis C
Janssen
Gilead
JNJ
Vertex
simeprevir
sofosbuvir
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
biotech
Alkermes
Celgene
AstraZeneca
Coronado Biosciences
Dendreon
Incyte
Isis Pharmaceuticals
JNJ
Eli Lilly
Merck
Novavax
Novartis
Pfizer
Sangamo BioSciences
Pharmacyclics
New Data Improves Sales Outlook For Celgene's Apremilast
TheStreet.com
Wed, 06/12/13 - 08:52 am
Celgene
apremilast
JNJ
Amgen
AbbVie
psoriatic arthritis
J&J's Stelara effective in psoriatic arthritis trial
Reuters
Tue, 06/11/13 - 10:45 pm
JNJ
Stelara
psoriatic arthritis
5 Drugs Stocks On The Rise
TheStreet.com
Mon, 06/10/13 - 08:03 pm
Acadia
Novartis
Teva
JNJ
Merck
For Johnson & Johnson: Recalls Keep Piling Up
Wall St. Cheat Sheet
Fri, 06/7/13 - 05:48 pm
recalls
JNJ
The Dope On A Forest Labs Takeover
Seeking Alpha
Tue, 06/4/13 - 12:57 pm
Forest Labs
M&A
JNJ
Eli Lilly
Merck
Pfizer
J&J Recalls 32 Million Boxes Of Contraceptives From 43 Countries
Pharmalot
Tue, 06/4/13 - 12:51 pm
JNJ
contraceptives
recalls
Johnson & Johnson's Potential Blockbuster For Multiple Myeloma And Its Competitors
Seeking Alpha
Tue, 06/4/13 - 09:36 am
JNJ
Multiple Myeloma
daratumumab
Genmab
Drugs Go From Hit to Dud in Two Years in Hepatitis Race
Bloomberg
Mon, 06/3/13 - 10:27 am
hepatitis C
Merck
Gilead
Vertex Pharmaceuticals
JNJ
Medivir
Bristol-Myers Squibb
Where to Invest for More Health-Care Exposure
Motley Fool
Sat, 06/1/13 - 12:22 pm
Pfizer
Merck
JNJ
Idenix Pharma Initiates Phase II Study
Yahoo/Zacks
Sat, 06/1/13 - 12:06 pm
Idenix
hepatitis C
hepatitis
samatasvir
IDX719
simeprevir
TMC435
JNJ
The Race For Oral HCV?
Seeking Alpha
Fri, 05/31/13 - 12:57 pm
AbbVie
Gilead
JNJ
Merck
Vertex Pharmaceuticals
hepatitis C
Making The Call: Pharmacyclics FDA Drug Approval Before Year End
TheStreet.com
Wed, 05/29/13 - 08:18 am
FDA
Pharmacyclics
JNJ
ibrutinib
B-cell cancers
Pages
« first
‹ previous
…
116
117
118
119
120
121
122
123
124
…
next ›
last »